Division of Pulmonary and Critical Care Medicine, Department of Medicine, Faculty of Medicine, Thammasat University, Bangkok, Bangkok, 12120, Thailand.
Department of Medicine, Faculty of Medicine, Thammasat University, Bangkok, Bangkok, 12120, Thailand.
F1000Res. 2024 May 31;13:296. doi: 10.12688/f1000research.146498.2. eCollection 2024.
Pulmonary involvement is a major cause of internal organ complication and the leading cause of death in patients with systemic sclerosis (SSc). This study aimed to demonstrate the characteristics of pulmonary function (PF) in Thai patients with SSc and the association between PF and body mass index (BMI) and anti-topoisomerase (anti-Scl70).
All patients diagnosed with SSc in our tertiary care teaching hospital database between 2016 and 2021 were reviewed and analyzed.
Of 211 SSc patients, 128 patients who underwent the PF test were enrolled; 102 (79.7%) were female. The mean age was 54 years. The median BMI for all patients was 21.7 kg/m . Regarding anti-Scl70, 10.9% of patients were positive, 7.8% were negative, and the status was unreported for 81.3%. The mean (SD) forced expiratory volume in one second (FEV1) forced vital capacity (FVC) ratio was 0.8 (0.1). The mean (SD) % predicted values of FEV1, FVC, and diffusing capacity of the lungs for carbon monoxide (DLCO) were 76.3 (16.3), 69.1 (15.8), and 75.5 (22.8), respectively. A restrictive spirometry pattern (RSP) was found in 78.8% of the patients. DLCO had a moderate positive linear correlation with FVC (r=0.50, p <0.001) and a moderate negative linear correlation with BMI (r=-0.36, p <0.001). However, there was no correlation between FVC and BMI. There was no statistical difference in demographic data or the presence of anti-Scl70 among patients with or without RSP.
RSP is common among Thai patients with SSc. However, the power of using demographic data and the presence of anti-Scl70 to determine the probability of pulmonary involvement remains limited.
肺部受累是系统性硬皮病(SSc)患者发生内脏器官并发症的主要原因,也是导致其死亡的主要原因。本研究旨在展示泰国 SSc 患者的肺功能(PF)特征,以及 PF 与体重指数(BMI)和抗拓扑异构酶(抗-Scl70)之间的关系。
回顾并分析了 2016 年至 2021 年期间我院三级保健教学医院数据库中诊断为 SSc 的所有患者。
211 例 SSc 患者中,有 128 例患者接受了 PF 检测,其中 102 例(79.7%)为女性,平均年龄为 54 岁。所有患者的 BMI 中位数为 21.7kg/m²。关于抗-Scl70,10.9%的患者为阳性,7.8%为阴性,81.3%的患者状态未报告。用力肺活量(FVC)与第一秒用力呼气量(FEV1)比值的平均(SD)为 0.8(0.1)。FEV1、FVC 和一氧化碳弥散量(DLCO)的预计值的平均(SD)分别为 76.3(16.3)、69.1(15.8)和 75.5(22.8)。78.8%的患者存在限制性肺通气功能障碍(RSP)。DLCO 与 FVC 呈中度正线性相关(r=0.50,p<0.001),与 BMI 呈中度负线性相关(r=-0.36,p<0.001)。然而,FVC 与 BMI 之间无相关性。存在或不存在 RSP 的患者在人口统计学数据或抗-Scl70 阳性方面无统计学差异。
RSP 在泰国 SSc 患者中较为常见。然而,利用人口统计学数据和抗-Scl70 阳性来确定肺部受累的可能性的能力仍然有限。